← Back to Clinical Trials
Recruiting NCT05929430

NCT05929430 Mindfulness in University Students. ATENEU Program

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05929430
Status Recruiting
Phase
Sponsor Universidad Miguel Hernandez de Elche
Condition Occupational Balance
Study Type INTERVENTIONAL
Enrollment 174 participants
Start Date 2023-11-02
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Mindfulness programMindfulness program with Virtual Reality

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 174 participants in total. It began in 2023-11-02 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study aims to examine the effects of a mindfulness-based intervention and a mindfulness-based intervention with virtual reality on occupational balance and on the reduction of psychological distress in university students (i.e. stress, anxiety and depression). The specific objectives will be to examine the effects of the intervention on other variables related to mental health, psychological functioning and occupations, and their maintenance at three months.

Eligibility Criteria

Inclusion Criteria: * being 18 years old or older * being a degree, master or doctorate student at Miguel Hernández University * speaking fluent Spanish * signing the informed consent form * having attended at least 4 of the 6 sessions (66% of the program) * internet access from a computer or smartphone to complete the online assessments and formal practices during the program. Exclusion Criteria: * miss more than 2 out of 6 sessions (33% of the program) * present a severe mental disorder in active phase diagnosed by a health professional (e.g., schizophrenia, bipolar disorder) * are under the influence of alcohol or other drugs during sessions and/or assessments (determined by the program instructor) * participate in another standardized meditation program during the study period * withdrew before starting the intervention. * Additionally, should any participants require psychological or psychiatric treatment during the study, they will be excluded and referred to specialized care services.

Contact & Investigator

Central Contact

Alicia Sánchez Pérez, Ph.D

✉ alicia.sanchez@umh.es

📞 654486081

Principal Investigator

Alicia Sánchez Pérez, Ph.D

PRINCIPAL INVESTIGATOR

Universidad Miguel Hernández- Facultad de Medicina

Frequently Asked Questions

Who can join the NCT05929430 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Occupational Balance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05929430 currently recruiting?

Yes, NCT05929430 is actively recruiting participants. Contact the research team at alicia.sanchez@umh.es for enrollment information.

Where is the NCT05929430 trial being conducted?

This trial is being conducted at Sant Joan d'Alacant, Spain.

Who is sponsoring the NCT05929430 clinical trial?

NCT05929430 is sponsored by Universidad Miguel Hernandez de Elche. The principal investigator is Alicia Sánchez Pérez, Ph.D at Universidad Miguel Hernández- Facultad de Medicina. The trial plans to enroll 174 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology